⏳ Fetching live dividend data...
Home › Calculator › NHWK Dividend Calculator 2026
NightHawk Biosciences, Inc. · AMEX
Price: $0.41 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NHWK → $3010743904675066880.00M in 10 years · $250,844,678,771,096,800,000,000.00/month
NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform. This platform encompasses two key technologies: ImPACT, an allogeneic (off-the-shelf) cell-based system designed to activate and expand T-cells, acting as a broad immune stimulant; and ComPACT, which combines antigen-specific T-cell activation with targeted co-stimulation in a single product. NightHawk's clinical pipeline features several promising candidates: HS-110, which has completed enrollment for its Phase II clinical trial, targeting advanced non-small cell lung cancer; and HS-130, currently undergoing a Phase I clinical trial for advanced solid tumors. Additionally, PTX-35, a novel T-cell co-stimulator agonist antibody that specifically targets DR3/TNFRSF25, is also in Phase I development. The company is also exploring DR3/TNFRSF25 as a general target for various immunotherapy applications. Beyond these, a COVID-19 vaccine is currently in preclinical stages. A notable collaboration involves Dr. James Shapiro at the University of Alberta, focusing on the manufacturing of a surrogate mouse version of PTX-35. Originally established as Heat Biologics, Inc. in 2008, the company rebranded to NightHawk Biosciences, Inc. in May 2022. Its headquarters are located in Morrisville, North Carolina.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NHWK position with:
Real after-tax yield depends on where you live and how you hold NHWK.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 483.68% | 480.88% | $48,368 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 411.13% | 408.33% | $41,113 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 386.94% | 384.14% | $38,694 / yr |
| 🇬🇧 UK ISA | 0% | 483.68% | 480.88% | $48,368 / yr |
| 🇬🇧 UK Taxable | 8.75% | 441.36% | 438.56% | $44,136 / yr |
| 🇨🇦 TFSA | 0% | 483.68% | 480.88% | $48,368 / yr |
| 🇨🇦 CA Taxable | 25% | 362.76% | 359.96% | $36,276 / yr |
| 🇦🇺 Super (pension) | 15% | 411.13% | 408.33% | $41,113 / yr |
| 🇦🇺 AU Taxable | 30% | 338.58% | 335.78% | $33,858 / yr |
| 🇩🇪 DE Taxable | 26.375% | 356.11% | 353.31% | $35,611 / yr |
| 🇫🇷 FR Taxable | 30% | 338.58% | 335.78% | $33,858 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
NHWK pays quarterly — 4 times per year. Next ex-div: TBD.
How NHWK compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NHWK sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2022-12-07 | 2,843,137 | — | — | ||
| A-Award | 2022-12-07 | 101,960 | — | — | ||
| A-Award | 2022-12-07 | 203,921 | — | — | ||
| A-Award | 2022-12-07 | 490,196 | — | — | ||
| A-Award | 2022-12-07 | 101,960 | — | — | ||
| A-Award | 2021-12-30 | 129,820 | $4.06 | $527.1K | ||
| J-Other | 2021-12-30 | 129,820 | $4.06 | $527.1K | ||
| A-Award | 2021-12-30 | 32,467 | $4.06 | $131.8K | ||
| J-Other | 2021-12-30 | 32,467 | $4.06 | $131.8K | ||
| A-Award | 2021-12-30 | 231,987 | $4.07 | $943.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NHWK dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
NightHawk Biosciences, Inc. (NHWK) is currently trading at $0.41, 95% below its 52-week high. The current dividend yield is 483.68% based on an annual payout of $2.00 per share.
NightHawk Biosciences, Inc. (NHWK) is a healthcare stock currently trading at $0.41 with a dividend yield of 483.68%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever